ADM DE111™ Probiotic for Gut Health Approved for Sale in China

Shanghai, April 23, 2024–ADM, a global leader in human and animal nutrition (New York Stock Exchange ticker: ADM), announced its Bacillus subtilis DE111™, a probiotic strain, has formally received approval from the National Health Commission to be launched in China. The approval from the Commission signifies that the DE111™ probiotic has passed rigorous evaluations and meets stringent quality and safety requirements for sale in the Chinese market. To date, ADM is the first and only supplier to offer Bacillus subtilis food ingredients to the Chinese market. (Source: Ringier)

Sign Up to Receive China Updates Weekly Newsletter for FREE, HERE

Visit HPA-China’s Information Hub, HERE